CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. (CBAY) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CBAY · as of Mar 31, 2024
Ownership Breakdown
2
Institutional Holders
▼ 223 vs Q4
$39,642
Total Inst. Value
▼ $2.71B vs Q4
114.78M
Shares Outstanding
freeFloat 84.19%
1,436
13F Shares Held
▼ 114.83M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CBAY largest shareholders · institutional ownership
Q1 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
EVERSOURCE WEALTH ADVISORS, LLC pharmaceutical preparations | 786 | 0.07% | 0.07% | $18.57M | May 13, 2024 | — held |
IFP ADVISORS, INC pharmaceutical preparations | 650 | 0.06% | 0.06% | $21.08M | Jul 30, 2024 | — held |
PRINCIPAL SECURITIES, INC. pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 10, 2024 | EXIT |
US BANCORP \DE\ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 8, 2024 | EXIT |
FRANKLIN RESOURCES INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 13, 2024 | EXIT |
JENNISON ASSOCIATES LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 2, 2024 | EXIT |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 10, 2024 | EXIT |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 15, 2024 | EXIT |
NORTHERN TRUST CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 14, 2024 | EXIT |
JPMORGAN CHASE & CO pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Dec 26, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2024 vs prior quarter
Q1 2024
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares48
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
-48
0 new / 48 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CBAY insider trading · insider activity
Source: SEC Form 4
35
Buy transactions
118
Sell transactions
0.30
Buy/Sell ratio
$10M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Loewy Caroline M director | Mar 22, 2024 | D-Return | 32,000 | $5.78 | $185.0K | 0 | Form 4 ↗ |
Loewy Caroline M director | Mar 22, 2024 | D-Return | 30,000 | $1.72 | $51.6K | 0 | Form 4 ↗ |
Loewy Caroline M director | Mar 22, 2024 | D-Return | 15,000 | $5.50 | $82.5K | 0 | Form 4 ↗ |
Loewy Caroline M director | Mar 22, 2024 | D-Return | 7,500 | $7.47 | $56.0K | 0 | Form 4 ↗ |
Loewy Caroline M director | Mar 22, 2024 | D-Return | 16,000 | $11.69 | $187.0K | 0 | Form 4 ↗ |
Loewy Caroline M director | Mar 22, 2024 | D-Return | 27,705 | $8.43 | $233.6K | 0 | Form 4 ↗ |
Loewy Caroline M director | Mar 22, 2024 | D-Return | 49,245 | $4.05 | $199.4K | 0 | Form 4 ↗ |
Loewy Caroline M director | Mar 22, 2024 | D-Return | 67,000 | $2.94 | $197.0K | 0 | Form 4 ↗ |
Loewy Caroline M director | Mar 22, 2024 | D-Return | 25,000 | $7.80 | $195.0K | 0 | Form 4 ↗ |
Loewy Caroline M director | Mar 22, 2024 | D-Return | 14,010 | $22.85 | $320.1K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
CymaBay Therapeutics, Inc. (CBAY) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 15.81%, while retail and public investors account for the remaining 84.19%.
The largest institutional shareholder of CymaBay Therapeutics, Inc. is EVERSOURCE WEALTH ADVISORS, LLC, holding approximately 786 shares — equal to 0.07% of outstanding shares — as of March 31, 2024.
A total of 2 institutional investors currently hold CBAY stock, with a combined institutional value of approximately $39,642 as of the most recent 13F filing period.
Frequently asked questions
CBAY ownershipCymaBay Therapeutics, Inc. (CBAY) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is EVERSOURCE WEALTH ADVISORS, LLC with a 0.07% stake. Company insiders hold 15.81%. Data sourced from SEC Form 13F as of March 31, 2024.